Condition

Antineutrophil Cytoplasmic Antibody-associated Vasculitis clinical trials and research

• 2Clinical trials
• 7Countries

All recruiting trials (2)

• Using engineered natural killer cells to treat immune-mediated diseases

  This study is testing a new type of cell therapy called NKX019 to see if it can safely help people with immune-related diseases like systemic sclerosis and certain types of myopathies.

  Recruiting at 12 sites Phase 1/2 Nkarta, Inc. · Los Angeles, California and 11 other locations · NCT06733935

• Evaluating Avacopan for ANCA-associated Vasculitis

  This study is testing if the medication avacopan is safe for people with ANCA-associated vasculitis who need strong treatments like cyclophosphamide or rituximab.

  Recruiting at 79 sites Phase 4 Amgen · Anchorage, Alaska and 82 other locations · NCT06072482

Related topics

Quick answers

How many Antineutrophil Cytoplasmic Antibody-associated Vasculitis clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 7 countries. The most sites are in United States (2 trials), Czechia (1 trial), Denmark (1 trial), Greece (1 trial), Hungary (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →